Quantinno Capital Management LP Supernus Pharmaceuticals, Inc. Transaction History
Quantinno Capital Management LP
- $15 Billion
- Q1 2025
A detailed history of Quantinno Capital Management LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 10,371 shares of SUPN stock, worth $345,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,371
Previous 8,401
23.45%
Holding current value
$345,043
Previous $303,000
11.88%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$346 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$205 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$173 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$96.6 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$89.8 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.78B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...